Chidinma Chima-Melton
8PUBLICATIONS
32CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Oct 15, 2024
Remdesivir Effectiveness in Reducing the Risk of 30-Day Readmission in Vulnerable Patients Hospitalized for COVID-19: A Retrospective US Cohort Study Using Propensity Scores.Essy Mozaffari, Aastha Chandak, Robert L Gottlieb
|Oct 15, 2024
Remdesivir-Associated Survival Outcomes Among Immunocompromised Patients Hospitalized for COVID-19: Real-world Evidence From the Omicron-Dominant Era.Essy Mozaffari, Aastha Chandak, Robert L Gottlieb
|Sep 20, 2024
Lower Mortality Risk Associated With Remdesivir + Dexamethasone Versus Dexamethasone Alone for the Treatment of Patients Hospitalized for COVID-19.Essy Mozaffari, Aastha Chandak, Robert L Gottlieb
|Jun 19, 2024
Remdesivir is Associated with Reduced Mortality in Patients Hospitalized for COVID-19 Not Requiring Supplemental Oxygen.Essy Mozaffari, Aastha Chandak, Chidinma Chima-Melton
|Feb 29, 2024
Treatment of patients hospitalized for COVID-19 with remdesivir is associated with lower likelihood of 30-day readmission: a retrospective observational study.Essy Mozaffari, Aastha Chandak, Robert L Gottlieb
|Feb 27, 2024
Racial and Ethnic Disparities in COVID-19 Treatments in the United States.Essy Mozaffari, Aastha Chandak, Alpesh N Amin
Pageof 2
Frequent Collaborators
5 joint publications
Mark Berry
5 joint publications
Andre C Kalil
5 joint publications
Robert L Gottlieb
5 joint publications
Aastha Chandak
4 joint publications
Alpesh N Amin
3 joint publications
Thomas Oppelt
1 joint publications
Matthew Chenoweth
1 joint publications
Heng Jiang
1 joint publications
Miguel Cuevas
1 joint publications
Sitaram Vangala
